Advanced Biomed ADVB Cash Flow Statement (2023-2026)

NASDAQ ADVB
$2.53 -0.78 (-23.56%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Advanced Biomed Quarterly Cash Flow Statement

Periods 12 quarters
Latest Sep 2026

Advanced Biomed reported cash from operations of -$0.17M and free cash flow of -$0.17M for the quarter ended Sep 2026. This cash flow statement covers 12 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income -0.15M-1.06M-0.81M-0.27M-0.91M-1.38M-0.70M-0.39M6.86M-0.49M0.69M-0.99M
Depreciation and DepletionDep. & Depletion 0.06M0.05M0.12M0.07M0.02M0.02M0.16M0.05M0.01M0.01M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.06M0.08M0.15M0.10M-0.06M0.02M0.28M0.05M-0.01M0.01M
Cash from Discontinued OperationsCash from Discont. Ops 2.03M-5.15M-0.11M
Gains from Sales and DivestituresGains Divest 61.007.35M6.67M
Change in Working Capital
Change in Accrued ExpensesChange Accrued Exp. 0.11M
Change in Other Operating AssetsOther Assets Change -0.10M
Change in Other Operating LiabilitiesOther Liabilities Change 0.00M-312.00-246.00-0.03M0.01M
Other Working Capital ChangesOther WC Changes 0.10M
Other non-cash itemsOther Non-Cash -19.00
Other Operating Activities (as filed) 104.00-90.00-112.00
Cash from OperationsCash from Ops. -0.17M
Investing Activities
Capital ExpendituresCapex -0.03M0.05M0.02M-0.01M0.00M0.02M0.00M0.01M0.00M
Change in Property, Plant and EquipmentChange in PP&E 0.03M-0.05M-0.02M0.01M0.00M-0.02M0.00M-0.01M0.00M
Cash from Investing ActivitiesCash from Investing 0.03M-0.05M-0.02M0.01M0.00M-0.02M0.00M-0.01M0.00M-2.57M
Other Investing Activities (as filed)Other investing (as filed) 0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.53M0.41M0.41M0.10M0.26M-0.49M0.46M-0.32M0.00M0.94M
Long-Term Debt RepaymentsLT Debt Repayment 0.00M0.84M0.01M0.01M
Net Long-Term Debt Issued (Repaid)Net LT Debt 0.53M0.41M0.41M0.10M0.26M-1.33M0.45M-0.33M0.00M0.94M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.53M0.41M0.41M0.10M0.26M-1.33M0.45M-0.33M0.00M0.94M
Change in Capital Stock
Common Stock IssuedStock Issued -0.02M-0.02M5.64M-0.11M6.56M-6.31M
Net Shares Issued and RepurchasedNet Shares Issued -0.02M-0.02M5.64M-0.11M6.56M-6.31M
Net Equity Issued and RepurchasedNet Equity Issued -0.02M-0.02M5.64M-0.11M6.56M-6.31M
Other financing activities (as filed) 0.29M0.35M
Cash from Financing ActivitiesCash from Financing 0.56M0.32M0.39M0.41M5.90M-0.77M0.45M0.32M0.27M0.94M
Additional items
Exchange Rate EffectFX Effect -76.00
Change in Cash -0.17M
Ending Cash Balance 0.21M
Free Cash FlowFCF -0.17M
Net Cash FlowNCF -0.17M
Interest Paid 104.0010.000.02M-90.000.01M448.000.01M-112.00

Advanced Biomed Cash Flow Statement API

Pull Advanced Biomed's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADVB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY